Lung Cancer Clinical Trial

Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC)

Summary

This project proposes to use bronchoscopic intratumoral chemotherapy for small cell lung cancer in two fashions:

to implement a prospective clinical trial to test the feasibility and efficacy of intralesional chemotherapy as consolidative therapy immediately following standard systemic chemotherapy and radiation therapy for patients with limited stage SCLC by comparing tumor growth and survival rates of the treatment group and compare the outcomes to historical controls
to implement a prospective clinical trial to test the feasibility and efficacy as measured by tumor growth and survival rates of intralesional chemotherapy for patients with recurrent SCLC after standard treatment.

View Full Description

Full Description

Subjects will receive standard of care treatment for SCLC with added treatment of Cisplatin injection via endobronchial ultrasound aided bronchoscopy a total of four times. Outcome measurements of tumor growth and survival will be compared to subjects receiving standard of care treatment only.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria: Competent adult English speaking subjects

With limited stage SCLC who have completed standard of care treatment who are responders with no evidence of disseminated disease other than CNS metastasis,
With recurrent disseminated SCLC after standard of care treatment with symptoms related to central tumor obstruction,
With recurrent limited stage SCLC with mediastinal/hilar recurrence not previously treated with intratumoral cisplatin

Exclusion Criteria:

Subjects who do not meet the inclusion criteria
Subjects who, in the opinion of the investigator, are at risk undergoing a bronchoscopy

Study is for people with:

Lung Cancer

Phase:

Phase 3

Estimated Enrollment:

4

Study ID:

NCT01487499

Recruitment Status:

Terminated

Sponsor:

University of Florida

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Florida
Gainesville Florida, 32610, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Phase:

Phase 3

Estimated Enrollment:

4

Study ID:

NCT01487499

Recruitment Status:

Terminated

Sponsor:


University of Florida

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider